Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
Před 798 dny
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
Před 1064 dny
Swiss Market Ends Modestly Lower
The Switzerland market closed on a weak note on Monday, after languishing in negative territory right through the day's trading session as investors remained hesitant to pick up stocks, choosing to wait for some crucial economic data, and the monetary policy announcements from several central banks.
RTTNews
|
Před 3 h 32 min
European Stocks Close Mostly Higher On Easing Trade Tensions
European stocks closed on a positive note on Monday with investors focusing on the upcoming monetary policy announcements from several central banks, including the European Central Bank, the Federal Reserve and the Bank of Japan, and following the developments on U.S.-China trade front.
RTTNews
|
Před 3 h 48 min
German Business Confidence Improves On Stronger Expectations: Ifo
Business morale in Germany rebounded more than expected in October as companies' expectations were the strongest in over three-and-a-half years, though they gave a weaker assessment of the current situation for a third month in a row, results of a closely watched survey by the ifo institute showed on Monday.
RTTNews
|
Před 6 h 6 min
Dollar Rebounds As US-China Trade Tensions Ease
The U.S. dollar ended up higher against major currencies during the week ended October 24 amidst an easing in trade tensions between the U.S. and China.
RTTNews
|
Před 7 h 32 min
Bay Street May Open On Mixed Note
The Canadian market is likely to open on a mixed note on Monday. Easing worries about U.S.-China trade tensions may aid sentiment, while weak commodity prices could weigh on resources stocks and limit market's upside, if any.
RTTNews
|
Před 9 h 18 min
FTSE 100 Moves In Tight Band; Fresnillo Down Sharply
UK stocks are moving in a tight range on Monday with investors mostly making cautious moves, looking ahead to the monetary policy meetings of the Federal Reserve, the European Central Bank and the Bank of Japan.
RTTNews
|
Před 10 h 10 min
